Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult – Business Wire (press release)
|
Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult
Business Wire (press release) LONDON–(BUSINESS WIRE)–Cell Medica today announced the acquisition of Catapult Therapy TCR Limited, a subsidiary of Cell and Gene Therapy Catapult (CGT Catapult), and the initiation of a collaboration to establish cell therapy manufacturing for Cell … Cell and Gene Therapy Catapult Announces Cell Medica Acquisition of WT1 T-cell Therapy |
